Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

HPV-Related Cervical Carcinoma Clinical Trial

Official title:

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03337269
• Other study ID #: 826486
• Status: Completed
• Phase: N/A
• First received: September 13, 2017
• Last updated: April 9, 2018
• Start date: March 1, 2017
• Est. completion date: February 15, 2018

Study information

• Verified date: April 2018
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 256
• Est. completion date: February 15, 2018
• Est. primary completion date: August 15, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 12 Years to 26 Years

Eligibility

Inclusion Criteria:

1. Females ages greater than or equal to 12 years and less than or equal to 26 years

2. Presenting to a gynecology clinic for a routine or problem visit

3. Ability to read and write

Exclusion Criteria:

1. Women ages less than or greater than 12 years or greater than 26 years

2. Women with known cervical cancer

3. Known pregnancy

4. Prior initiation or completion of the HPV vaccine series

Related Conditions & MeSH terms

• HPV-Related Cervical Carcinoma

Intervention

Other:
• Educational video
Approximately 7 minute video on the HPV vaccine
• Educational handout
One page handout on the HPV vaccine
• Control
Control

Locations

Country	Name	City	State
United States	University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HPV vaccine acceptability	Subject reported willingness to accept the HPV vaccination, as assessed through agreement or disagreement to the statement "I would be willing to accept the HPV vaccine today."	Up to 6 months
Secondary	HPV vaccine knowledge	Subject knowledge of the HPV vaccine and its associated risks and benefits, as assessed through a survey. Subjects are asked to answer 7 questions and total knowledge score is calculated by an unweighted sum of correct answers.	Up to 6 months